Press releases
April 06, 2021:
Santhera Commences Convertible Bond Exchange Offer and Continues to Seek Votes on the Bondholders' Resolution
March 30, 2021:
Santhera Completes Capital Increase for Financing Arrangements
March 25, 2021:
Santhera Launches Exchange Offer for its CHF 60 Million Convertible Bonds
March 18, 2021:
Santhera’s Shareholders Approve all Board Proposals at Today’s Extraordinary General Meeting
March 10, 2021:
Santhera Completes Capital Increase for Financing Arrangements
March 09, 2021:
Santhera Announces Results of Bondholders’ Meeting
March 03, 2021:
Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular Dystrophy
March 01, 2021:
Santhera Announces Positive Results with Lonodelestat in Early Phase Cystic Fibrosis Trial
February 24, 2021:
Santhera Calls Extraordinary General Meeting to Seek Approval for Proposed Strengthening of Capital Structure
February 16, 2021:
Santhera Announces Corporate Update and Proposal to Strengthen Capital Structure
February 05, 2021:
Santhera Completes Capital Increase for Financing Arrangements
